SCHEMBL3540730

SCHEMBL3540730

COc1ccc(Sc2ccccc2C2(O)CCN(C(=O)OC(C)(C)C)CC2)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.47
HTR3A P46098 1/20 0.47
ALDH1A1 P00352 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
STS P08842 2/20 0.39
PDK2 Q15119 1/20 0.39
GPR119 Q8TDV5 1/20 0.39
PIK3CA P42336 1/20 0.37
MTOR P42345 1/20 0.37
PRKDC P78527 1/20 0.37
EPHX2 P34913 1/20 0.37
ITGB2 P05107 1/20 0.37
ICAM1 P05362 1/20 0.37
ITGAL P20701 1/20 0.37
HTT P42858 1/20 0.37
USP30 Q70CQ3 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3544412 0.89 MEN1 (0.42) HTR1AHTR3AALDH1A1HDAC1HDAC8
SCHEMBL3539669 0.89 HTR1A (0.39) HTR1AHTR3AALDH1A1HDAC1STS
SCHEMBL3542345 0.86 ALDH1A1 (0.45) HTR1AHTR3AALDH1A1STSPDK2
SCHEMBL5740602 0.85 HTR1A (0.42) HTR1AHTR3AALDH1A1ITGB2ICAM1
SCHEMBL3544866 0.82 ANO1 (0.42) HDAC1HDAC8HDAC6STSPDK2
SCHEMBL3545542 0.82 CYP3A4 (0.44) HDAC1HDAC8HDAC6STSPDK2
SCHEMBL3543561 0.82 PDK2 (0.40) HDAC1HDAC8HDAC6STSPDK2
SCHEMBL3544616 0.81 MEN1 (0.46) ALDH1A1HDAC1HDAC8HDAC6STS
SCHEMBL13349785 0.80 GPR119 (0.44) HDAC1HDAC8HDAC6PDK2GPR119
SCHEMBL3545421 0.80 HDAC2 (0.40) HDAC1PDK2GPR119MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732463-B2 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors H. LUNDBECK A/S (DK) 2010-06-08 US disclosed
US-20060100242-A1 such as 4-[2-(4-Chloro-phenylsulfanyl)-5-trifluoromethyl-phenyl]-piperidine, used as antidepressants and anxiolytic agents; treatment of panic and obsessive compulsive disorders H.LUNDBECK A/S (DK) 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100242-A1 such as 4-[2-(4-Chloro-phenylsulfanyl)-5-trifluoromethyl-phenyl]-piperidine, used as antidepressants and anxiolytic agents; treatment of panic and obsessive compulsive disorders HTR4, HTR5A, TPH1 HTR1A 11/4885HTR3A 22/4885ALDH1A1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.